Please use this identifier to cite or link to this item: https://doi.org/10.32598/bcn.11.covid19.1
Title: COVID-19 and substance use disorders: Recommendations to a comprehensive healthcare response an international society of addiction medicine practice and policy interest group position paper
Authors: Farhoudian, A.
Baldacchino, A.
Clark, N.
Gerra, G.
Ekhtiari, H.
Dom, G.
Mokri, A.
Sadeghi, M.
Nematollahi, P.
Demasi, M.
Schutz, C.G.
Hashemian, S.M.
Tabarsi, P.
Galea-Singer, S.
Carra, G.
Clausen, T.
Kouimtsidis, C.
Tolomeo, S. 
Radfar, S.R.
Razaghi, E.M.
Keywords: Addiction medicine
Coronavirus
Coronavirus Disease 2019 (COVID-19)
Harm reduction
Methadone
Opioid substitution therapy
Pandemic
Policy
Public health
Substance use disorder
Issue Date: 2020
Publisher: Iran University of Medical Sciences
Citation: Farhoudian, A., Baldacchino, A., Clark, N., Gerra, G., Ekhtiari, H., Dom, G., Mokri, A., Sadeghi, M., Nematollahi, P., Demasi, M., Schutz, C.G., Hashemian, S.M., Tabarsi, P., Galea-Singer, S., Carra, G., Clausen, T., Kouimtsidis, C., Tolomeo, S., Radfar, S.R., Razaghi, E.M. (2020). COVID-19 and substance use disorders: Recommendations to a comprehensive healthcare response an international society of addiction medicine practice and policy interest group position paper. Basic and Clinical Neuroscience 11 (2) : 133-150. ScholarBank@NUS Repository. https://doi.org/10.32598/bcn.11.covid19.1
Rights: Attribution-NonCommercial 4.0 International
Abstract: Coronavirus Disease 2019 (COVID-19) is escalating all over the world and has higher morbidities and mortalities in certain vulnerable populations. People Who Use Drugs (PWUD) are a marginalized and stigmatized group with weaker immunity responses, vulnerability to stress, poor health conditions, high-risk behaviors, and lower access to health care services. These conditions put them at a higher risk of COVID-19 infection and its complications. In this paper, an international group of experts on addiction medicine, infectious diseases, and disaster psychiatry explore the possible raised concerns in this issue and provide recommendations to manage the comorbidity of COVID-19 and Substance Use Disorder (SUD). © 2020 Iran University of Medical Sciences. All rights reserved.
Source Title: Basic and Clinical Neuroscience
URI: https://scholarbank.nus.edu.sg/handle/10635/197938
ISSN: 2008-126X
DOI: 10.32598/bcn.11.covid19.1
Rights: Attribution-NonCommercial 4.0 International
Appears in Collections:Elements
Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_32598_bcn_11_covid19_1.pdf1.12 MBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons